Cite
HARVARD Citation
Cowan, R. et al. (2021). Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial. Journal of the European Academy of Dermatology and Venereology. pp. 2225-2238. [Online].